MUDI: A Multimodal Biomedical Dataset for Understanding Pharmacodynamic Drug-Drug Interactions

• URL: http://arxiv.org/abs/2506.01478v1
• Date: Mon, 02 Jun 2025 09:36:08 GMT
• Title: MUDI: A Multimodal Biomedical Dataset for Understanding Pharmacodynamic Drug-Drug Interactions
• Authors: Tung-Lam Ngo, Ba-Hoang Tran, Duy-Cat Can, Trung-Hieu Do, Oliver Y. Chén, Hoang-Quynh Le,
• Abstract summary: We introduce MUDI, a large-scale Multimodal biomedical dataset for Understanding pharmacodynamic Drug-drug Interactions.<n> MUDI provides a comprehensive multimodal representation of drugs by combining pharmacological text, chemical formulas, molecular structure graphs, and images across 310,532 annotated drug pairs.<n>We evaluate benchmark models using both late fusion voting and intermediate fusion strategies.
• Score: 2.402478832656235
• License: http://creativecommons.org/licenses/by-nc-sa/4.0/
• Abstract: Understanding the interaction between different drugs (drug-drug interaction or DDI) is critical for ensuring patient safety and optimizing therapeutic outcomes. Existing DDI datasets primarily focus on textual information, overlooking multimodal data that reflect complex drug mechanisms. In this paper, we (1) introduce MUDI, a large-scale Multimodal biomedical dataset for Understanding pharmacodynamic Drug-drug Interactions, and (2) benchmark learning methods to study it. In brief, MUDI provides a comprehensive multimodal representation of drugs by combining pharmacological text, chemical formulas, molecular structure graphs, and images across 310,532 annotated drug pairs labeled as Synergism, Antagonism, or New Effect. Crucially, to effectively evaluate machine-learning based generalization, MUDI consists of unseen drug pairs in the test set. We evaluate benchmark models using both late fusion voting and intermediate fusion strategies. All data, annotations, evaluation scripts, and baselines are released under an open research license.

Related papers

• Towards Interpretable Drug-Drug Interaction Prediction: A Graph-Based Approach with Molecular and Network-Level Explanations [3.6099926707292793]
  Drug-drug interactions (DDIs) represent a critical challenge in pharmacology, often leading to adverse drug reactions with significant implications for patient safety and healthcare outcomes.<n>We propose MolecBioNet, a novel graph-based framework that integrates molecular and biomedical knowledge for robust and interpretable DDI prediction.
  arXiv  Detail & Related papers  (2025-07-12T07:43:19Z)
• DNMDR: Dynamic Networks and Multi-view Drug Representations for Safe Medication Recommendation [9.504676133698895]
  This paper proposes a novel Medication Recommendation (MR) method with the integration of dynamic networks and multi-view drug representations (DNMDR)<n>The proposed DNMDR method outperforms the state-of-the-art baseline models with a large margin on various metrics such as PRAUC, Jaccard, DDI rates and so on.
  arXiv  Detail & Related papers  (2025-01-15T04:36:55Z)
• MD-Syn: Synergistic drug combination prediction based on the multidimensional feature fusion method and attention mechanisms [0.0]
  Drug combination therapies have shown promising therapeutic efficacy in complex diseases and have demonstrated the potential to reduce drug resistance.<n>The huge number of possible drug combinations makes it difficult to screen them all in traditional experiments.<n>In this study, we proposed MD-Syn, a computational framework, which is based on the multidimensional feature fusion method and multi-head attention mechanisms.
  arXiv  Detail & Related papers  (2025-01-14T06:50:56Z)
• KITE-DDI: A Knowledge graph Integrated Transformer Model for accurately predicting Drug-Drug Interaction Events from Drug SMILES and Biomedical Knowledge Graph [0.11049608786515838]
  Drug-Drug Interactions (DDI) can cause significant bodily injury and even death.<n>Most contemporary research for predicting DDI events relies on either information from Biomedical Knowledge graphs (KG) or drug SMILES.<n>In this study, we propose a KG-integrated Transformer architecture to generate an end-to-end fully automated Machine Learning pipeline.
  arXiv  Detail & Related papers  (2024-12-08T00:49:57Z)
• MIN: Multi-channel Interaction Network for Drug-Target Interaction with Protein Distillation [64.4838301776267]
  Multi-channel Interaction Network (MIN) is a novel framework designed to predict drug-target interaction (DTI)<n>MIN incorporates a representation learning module and a multi-channel interaction module.<n>MIN is not only a potent tool for DTI prediction but also offers fresh insights into the prediction of protein binding sites.
  arXiv  Detail & Related papers  (2024-11-23T05:38:36Z)
• A Cross-Field Fusion Strategy for Drug-Target Interaction Prediction [85.2792480737546]
  Existing methods fail to utilize global protein information during DTI prediction. Cross-field information fusion strategy is employed to acquire local and global protein information. Siamese drug-target interaction SiamDTI prediction method achieves higher accuracy levels than other state-of-the-art (SOTA) methods on novel drugs and targets.
  arXiv  Detail & Related papers  (2024-05-23T13:25:20Z)
• Multiscale Topology in Interactomic Network: From Transcriptome to Antiaddiction Drug Repurposing [0.3683202928838613]
  The escalating drug addiction crisis in the United States underscores the urgent need for innovative therapeutic strategies. This study embarked on an innovative and rigorous strategy to unearth potential drug repurposing candidates for opioid and cocaine addiction treatment.
  arXiv  Detail & Related papers  (2023-12-03T04:01:38Z)
• Decision Support System for Chronic Diseases Based on Drug-Drug Interactions [67.9840225237587]
  This paper presents a Decision Support System, called DSSDDI, based on drug-drug interactions to support doctors prescribing decisions. The DDI module learns safer and more effective drug representations from the drug-drug interactions. The MD module considers the representations of patients and drugs as context, DDI and patients' similarity as treatment, and medication use as outcome.
  arXiv  Detail & Related papers  (2023-03-04T12:44:38Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity Prediction [127.43571146741984]
  Drug-Target Affinity (DTA) is of vital importance in early-stage drug discovery. wet experiments remain the most reliable method, but they are time-consuming and resource-intensive. Existing methods have primarily focused on developing techniques based on the available DTA data, without adequately addressing the data scarcity issue. We present the SSM-DTA framework, which incorporates three simple yet highly effective strategies.
  arXiv  Detail & Related papers  (2022-06-20T14:53:25Z)
• Multi-View Substructure Learning for Drug-Drug Interaction Prediction [69.34322811160912]
  We propose a novel multi- view drug substructure network for DDI prediction (MSN-DDI) MSN-DDI learns chemical substructures from both the representations of the single drug (intra-view) and the drug pair (inter-view) simultaneously and utilizes the substructures to update the drug representation iteratively. Comprehensive evaluations demonstrate that MSN-DDI has almost solved DDI prediction for existing drugs by achieving a relatively improved accuracy of 19.32% and an over 99% accuracy under the transductive setting.
  arXiv  Detail & Related papers  (2022-03-28T05:44:29Z)
• Predicting Drug-Drug Interactions from Heterogeneous Data: An Embedding Approach [20.87835183671462]
  We present the first work that uses multiple data sources such as drug structure images, drug structure string representation and relational representation of drug relationships as the input. Our empirical evaluation against several state-of-the-art methods using standalone different data types for drugs clearly demonstrate the efficacy of combining heterogeneous data in predicting DDIs.
  arXiv  Detail & Related papers  (2021-03-19T17:25:48Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.